Zimbabwe has turned down a major American healthcare agreement worth $367m (£272m) over five years due to Washington's request for confidential data.
This rejection was revealed after a government memo dated December was leaked, revealing that President Emmerson Mnangagwa believed the arrangement was "lopsided".
A government representative later stated that the United States was seeking genetic material for scientific study and commercial purposes while refused to share the benefits from any future medical innovations.
"We must now begin the challenging and unfortunate task of scaling back our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had provided over $1.9bn in health funding to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has urged further talks to find a deal agreeable to all parties so the country's vital HIV treatment initiative can continue.
Wider Context
This development comes after a similar situation in neighbouring Kenya, where a court halted a similar health funding agreement after legal challenges were raised about the safety of Kenyans' health data.
After resuming office recently, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
The agency had overseen aid for the American government, but Trump stated its spending was "inefficient" and his government was pursuing government-to-government deals to enhance transparency and responsibility.
As per reports, Sixteen nations in Africa have so far agreed to these new health pacts, constituting more than $18.3bn in new funding.
Specifics of the Rejected Deal
The money for Zimbabwe was intended to supported "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership would have delivered extraordinary benefits for Zimbabwean communities, especially the 1.2 million presently receiving HIV treatment through American-funded initiatives," the Ambassador added.
However, official spokesman Nick Mangwana maintained the proposed deal was "asymmetrical".
"Zimbabwe was being asked to surrender its genetic material and health information for a long time, without any corresponding promise of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might result from that shared data," he stated.
"In essence, our country would supply the raw materials for medical research without any certainty that the final treatments would be available to our people should a new pandemic arise."
Sovereignty and International Frameworks
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting structures already set up through the global health agency.
Mangwana cited its Pandemic Benefit-Sharing framework created to deal with future global health emergencies.
"This mechanism is intended to ensure that when a nation provides its information, the resulting advantages – including medicines and cures – are shared equitably, not monopolised exclusively by those with the funds to develop them."
Zimbabwe's reservations regarding the US deal "are not meant as hostility towards the US," he added.
"We welcome ongoing discussions with our US partners on how subsequent co-operation might be designed in a manner that honours the independence and interests of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the government's concerns, but suggested that negotiations should continue considering a large portion of the country's Aids initiatives relied on international support.
"If specific concerns exist, including those relating to information security or implementation frameworks, these can frequently be resolved via detailed discussion and negotiated safeguards," it said.
This impasse emphasises the continuing challenges between accepting much-needed international aid and protecting a country's data in an increasingly interconnected world.